Follow
Tumor
Tumor: is an abnormal mass of tissue that may be solid or fluid-filled. A tumor is not the same as cancer. Although, some tumors can develop into cancers. A tumor is a kind of lump or swelling and does not necessarily pose a health threat.
-
MAR 21, 2017 | 10:00 AM
DATE: March 21, 2017TIME: 10:00am PT, 1:00pm ETSponsored By: Prostate cancer is a complex disease with multiple tumors originating independent...Speaker: Nallasivam Palanisamy, PhD , Courtney Anderson, PhDSponsored By: Novus Biologicals a Bio-Techne BrandFEB 23, 2017 | 12:00 PM
Despite vast investment for decades in cancer research and development, cancer is still among the leading causes of death worldwide and its toll is expected to rise by about 70% over the next...FEB 23, 2017 | 6:00 AM
Liquid Biopsies are gaining acceptance in the Oncology community as a surrogate or complement to the gold standard of tissue biopsy. A liquid biopsy provides biomarker information that...FEB 22, 2017 | 6:00 AM
Recent advances in DNA sequencing have now made it possible to characterize genomes, transcriptomes and even methylomes which is transforming both basic research and clinical practice. Whole...FEB 22, 2017 | 6:00 AM
The starting point for an interaction between a patient and a clinician is almost always a set of clinical facts (aka a phenotype). Phenotype-first medicine is the standard way in which the p...JAN 27, 2017 | 4:00 AM
DATE: January 27, 2017TIME: 4:00am PT, 7:00am ET, 1:00pm CETThe study of the tumor ecosystem and its cell-to-cell communications is essential to enable an understanding of tumor biology...Speaker: Bernd Bodenmiller, PhD , Randall Wetzel, PhDSponsored By: Cell Signaling Technology, Cell Signaling TechnologyJAN 19, 2017 | 8:00 AM
DATE: January 19th, 2017TIME: 8:00AM PT, 11:00AM ETLiquid biopsies have the potential to be a less invasive method than traditional biopsies to detect advanced solid tumor mutational st...JAN 17, 2017 | 8:00 AM
Review this powerful technique, get advice on selecting antibodies, and learn troubleshooting techniques with our Epigenetic specialist....Speaker: David GrotskyDEC 01, 2016 | 8:00 AM
DATE: December 1, 2016TIME: 8:00 AM PT, 11:00 AM ETPreclinical imaging enables the measurement and assessment of biological processes in vivo utilizing technologies such as biolum...NOV 17, 2016 | 9:00 AM
This panel will discuss quality requirements of ancillary materials used in cell therapy manufacturing, relevant standards and how requirements vary by phase. Participants will learn wh...Speaker: Joyce Frey-Vasconcells, PhD , Michael Mendicino, PhD , Kelli Tanzella, PhDPresented at: 4th Annual 24 Hours of Stem Cells™ virtual event
NOV 17, 2016 | 8:30 AM
DATE: November 17, 2016 TIME: 8:30am PT, 11:30am ET The complex interactions between transcription, translation, and post-translational modifications are hidden from view in typ...Speaker: Sara Becker-Catania, PhDNOV 16, 2016 | 8:00 AM
DATE: November 16, 2016 TIME: 8:00am PT, 11:00am ET Breast cancer is the most commonly diagnosed cancer in women and is the second leading cause of cancer death among wo...NOV 08, 2016 | 6:00 AM
Antibodies are used in a broad range of research and diagnostic applications for the enrichment, detection, and quantitation of proteins and their modifications. Hundreds of thousands o...Speaker: John Rogers, PhDNOV 04, 2016 | 10:00 AM
DATE: November 4, 2016 TIME: 10:00am PT, 1:00pm ET How do you develop clinically relevant biomarkers? Systematic tumor profiling with multi-omics tools and rapid analytical...Speaker: Antonia Sepulveda, MD, PhD , Yang Yang, PhD , Tamara Lotan, MDSponsored By: Affymetrix, AffymetrixNOV 03, 2016 | 1:30 PM
We describe a novel method to measure 1,25(OH)2D. Briefly, this method was built on four pillars: (1) the nuclear vitamin D receptor (VDR)`s ligand binding domain (LBD) as a capture mol...Speaker: Fabrizio Bonelli, PhDNOV 03, 2016 | 12:00 PM
Breast cancer is a complex heterogeneous disease, with each subtype characterized by distinct clinical features and molecular alterations. The heterogeneity of breast cancer has presented mas...Speaker: Julie Deschenes, MBA, PhD , Dilhan Weeraratne, PhDNOV 03, 2016 | 7:30 AM
Fusion genes are hybrid genes formed by the fusion of two separate genes. Translocation, interstitial deletion and chromosomal inversions are some of the genetic events that can lead to the f...NOV 01, 2016 | 8:00 AM
DATE: November 1, 2016 TIME: 8:00AM PT, 11:00AM ET Metastatic cancer is an evolving, heterogeneous disease that becomes more complex over time through the selection of sub-clonal tumor po...OCT 18, 2016 | 1:00 PM
Induced pluripotent stem cells derived from patient cells have emerged as complementary tools to study human neurological disorders. Neurxstem Inc has generated human iPSC-derived synth...OCT 11, 2016 | 7:00 AM
DATE: October 11, 2016 TIME: 7:00am PT, 10:00am ET Monoclonal antibodies (mAbs) have emerged as important therapeutics for the treatment of life-threatening diseases. The succ...OCT 06, 2016 | 10:30 AM
New generations of treatments successfully target cancer cell signaling and modulate anti-cancer immunity to improve outcomes for advanced-stage malignancies. Such clinical responses are gove...Speaker: Jonathan Irish, PhDOCT 06, 2016 | 10:30 AM
Tumors often evade immune destruction by adapting and circumventing immune checkpoints to create resistance. This adaptive immunity can be reversed to stimulate the endogenous immune re...Speaker: Erin Newburn, MS, PhDOCT 06, 2016 | 9:00 AM
The immune system is capable of recognizing tumors and eliminates many early malignant cells. However, tumors evolve to evade immune attack, and the tumor microenvironment is immunosuppressiv...Speaker: Gordon Freeman, PhDOCT 06, 2016 | 7:30 AM
Intra-tumor heterogeneity is a major obstacle to cancer treatment. Existing single-cell studies of intra-tumor heterogeneity have largely focused on DNA mutations; functional heterogeneity is...Speaker: Shyam Prabhakar, PhD
MAR 21, 2017 | 10:00 AM
DATE: March 21, 2017TIME: 10:00am PT, 1:00pm ETSponsored By: Prostate cancer is a complex disease with multiple tumors originating independent...
Speaker:
Nallasivam Palanisamy, PhD
, Courtney Anderson, PhD
Sponsored By: Novus Biologicals a Bio-Techne Brand
FEB 23, 2017 | 12:00 PM
Despite vast investment for decades in cancer research and development, cancer is still among the leading causes of death worldwide and its toll is expected to rise by about 70% over the next...
FEB 23, 2017 | 6:00 AM
Liquid Biopsies are gaining acceptance in the Oncology community as a surrogate or complement to the gold standard of tissue biopsy. A liquid biopsy provides biomarker information that...
FEB 22, 2017 | 6:00 AM
Recent advances in DNA sequencing have now made it possible to characterize genomes, transcriptomes and even methylomes which is transforming both basic research and clinical practice. Whole...
FEB 22, 2017 | 6:00 AM
The starting point for an interaction between a patient and a clinician is almost always a set of clinical facts (aka a phenotype). Phenotype-first medicine is the standard way in which the p...
JAN 27, 2017 | 4:00 AM
DATE: January 27, 2017TIME: 4:00am PT, 7:00am ET, 1:00pm CETThe study of the tumor ecosystem and its cell-to-cell communications is essential to enable an understanding of tumor biology...
Speaker:
Bernd Bodenmiller, PhD
, Randall Wetzel, PhD
Sponsored By: Cell Signaling Technology,
Cell Signaling Technology
JAN 19, 2017 | 8:00 AM
DATE: January 19th, 2017TIME: 8:00AM PT, 11:00AM ETLiquid biopsies have the potential to be a less invasive method than traditional biopsies to detect advanced solid tumor mutational st...
JAN 17, 2017 | 8:00 AM
Review this powerful technique, get advice on selecting antibodies, and learn troubleshooting techniques with our Epigenetic specialist....
Speaker:
David Grotsky
DEC 01, 2016 | 8:00 AM
DATE: December 1, 2016TIME: 8:00 AM PT, 11:00 AM ETPreclinical imaging enables the measurement and assessment of biological processes in vivo utilizing technologies such as biolum...
NOV 17, 2016 | 9:00 AM
This panel will discuss quality requirements of ancillary materials used in cell therapy manufacturing, relevant standards and how requirements vary by phase. Participants will learn wh...
Speaker:
Joyce Frey-Vasconcells, PhD
, Michael Mendicino, PhD
, Kelli Tanzella, PhD
Presented at: 4th Annual 24 Hours of Stem Cells™ virtual event
NOV 17, 2016 | 8:30 AM
DATE: November 17, 2016
TIME: 8:30am PT, 11:30am ET
The complex interactions between transcription, translation, and post-translational modifications are hidden from view in typ...
Speaker:
Sara Becker-Catania, PhD
NOV 16, 2016 | 8:00 AM
DATE: November 16, 2016
TIME: 8:00am PT, 11:00am ET
Breast cancer is the most commonly diagnosed cancer in women and is the second leading cause of cancer death among wo...
NOV 08, 2016 | 6:00 AM
Antibodies are used in a broad range of research and diagnostic applications for the enrichment, detection, and quantitation of proteins and their modifications. Hundreds of thousands o...
Speaker:
John Rogers, PhD
NOV 04, 2016 | 10:00 AM
DATE: November 4, 2016
TIME: 10:00am PT, 1:00pm ET
How do you develop clinically relevant biomarkers?
Systematic tumor profiling with multi-omics tools and rapid analytical...
Speaker:
Antonia Sepulveda, MD, PhD
, Yang Yang, PhD
, Tamara Lotan, MD
Sponsored By: Affymetrix,
Affymetrix
NOV 03, 2016 | 1:30 PM
We describe a novel method to measure 1,25(OH)2D. Briefly, this method was built on four pillars: (1) the nuclear vitamin D receptor (VDR)`s ligand binding domain (LBD) as a capture mol...
Speaker:
Fabrizio Bonelli, PhD
NOV 03, 2016 | 12:00 PM
Breast cancer is a complex heterogeneous disease, with each subtype characterized by distinct clinical features and molecular alterations. The heterogeneity of breast cancer has presented mas...
Speaker:
Julie Deschenes, MBA, PhD
, Dilhan Weeraratne, PhD
NOV 03, 2016 | 7:30 AM
Fusion genes are hybrid genes formed by the fusion of two separate genes. Translocation, interstitial deletion and chromosomal inversions are some of the genetic events that can lead to the f...
NOV 01, 2016 | 8:00 AM
DATE: November 1, 2016
TIME: 8:00AM PT, 11:00AM ET
Metastatic cancer is an evolving, heterogeneous disease that becomes more complex over time through the selection of sub-clonal tumor po...
OCT 18, 2016 | 1:00 PM
Induced pluripotent stem cells derived from patient cells have emerged as complementary tools to study human neurological disorders. Neurxstem Inc has generated human iPSC-derived synth...
OCT 11, 2016 | 7:00 AM
DATE: October 11, 2016
TIME: 7:00am PT, 10:00am ET
Monoclonal antibodies (mAbs) have emerged as important therapeutics for the treatment of life-threatening diseases. The succ...
OCT 06, 2016 | 10:30 AM
New generations of treatments successfully target cancer cell signaling and modulate anti-cancer immunity to improve outcomes for advanced-stage malignancies. Such clinical responses are gove...
Speaker:
Jonathan Irish, PhD
OCT 06, 2016 | 10:30 AM
Tumors often evade immune destruction by adapting and circumventing immune checkpoints to create resistance. This adaptive immunity can be reversed to stimulate the endogenous immune re...
Speaker:
Erin Newburn, MS, PhD
OCT 06, 2016 | 9:00 AM
The immune system is capable of recognizing tumors and eliminates many early malignant cells. However, tumors evolve to evade immune attack, and the tumor microenvironment is immunosuppressiv...
Speaker:
Gordon Freeman, PhD
OCT 06, 2016 | 7:30 AM
Intra-tumor heterogeneity is a major obstacle to cancer treatment. Existing single-cell studies of intra-tumor heterogeneity have largely focused on DNA mutations; functional heterogeneity is...
Speaker:
Shyam Prabhakar, PhD